article thumbnail

Bridging the healthcare digital divide: a gradual approach to adopting ePI

European Pharmaceutical Review

Within the EU, patient information leaflets (PILs) are not merely a regulatory requirement but a cornerstone of patient safety. They are vital to ensuring the safe and effective use of medicines, making them an integral part of healthcare in Europe. percent as EU average with some Member States as high as 25 percent).

article thumbnail

Unlocking the Potential of Healthcare Claims Data Part II: Optimizing Network Performance

Clarify Health

This is part two of our three-part series about how health plan leaders can leverage healthcare claims data to reduce costs , strategically grow their networks , provide best-in-class member services , and enhance outcomes for their members. And a reputation for excellence perennially appeals to current and prospective members.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Ampoules packaging market forecast to 2033

European Pharmaceutical Review

Expansion challenges for the market Factors expected to limit growth of the ampoule packaging market to 2033 includes the fragile nature of glass ampoules causing transportation, storage, and handling issues. This can raise safety concerns for patients, due to important information not being present on the packaging, the report stated.

article thumbnail

Delivery systems for biologics

European Pharmaceutical Review

Therefore, biologics identification and characterisation poses unparalleled challenges, as does their manufacturing processes and routes of administration while maintaining patient safety and clinical efficacy. Notably, LNPs facilitate the transportation of large payloads, have limited immunogenicity, and allow for scalable manufacturing.

article thumbnail

Dapagliflozin approved for heart failure across LVEFs

European Pharmaceutical Review

The Medicines and Healthcare products Regulatory Agency ( MHRA ) has granted a licence extension for FORXIGA (dapagliflozin) in Great Britain for symptomatic chronic heart failure (HF) across the full spectrum of left ventricular ejection fraction (LVEF). AstraZeneca’s oral dapagliflozin drug.

article thumbnail

Meet the company on a mission to transform research and advance healthcare

Pharmaceutical Technology

On the other hand, a lack of diversity in clinical trial populations, particularly when the disease population is significantly underrepresented, greatly diminishes the quality of data obtained for drug safety and efficacy profiles. This may sound obvious, but it is still a major hurdle in drug development.

article thumbnail

Putting Patients First: Improving the Pharmaceutical Supply Chain

Impetus Digital

Safety and Quality Control The safety and quality of medications are paramount when it comes to patient care. Unfortunately, many businesses in the healthcare industry fail to consider patient needs when managing their supply chains , which can have serious consequences.